retatrutide phase 3 trials VisualAbstract: reduces body weight by 17.5% in patients with obesity Lilly's triple agonist achieves 16.8%

It should not be used concurrently with other GLP-1 receptor agonists

"Care management is essential for those taking GLP-1 drugs, and when providers and prescribers have access to real-world data, they're better informed to manage drug dosages, monitor for potential adverse effects and help with other areas, such as diet and exercise coaching," said Marci Chodroff, M.D., vice president, medical director at Prime

2.4 Immunomodulatory and anti-inflammatory effects GLP-1 receptor agonists have substantial immunomodulatory effects that beyond basic metabolic control

What exercise is recommended

2025;388(6742):eadt0548

Maria's success story exemplifies how Expert GLP-1 Therapy, under the guidance of a knowledgeable healthcare provider like Dr